The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 20 August 2001. doi:10.1084/jem.194.4.491
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 296K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magnan, A.
Right arrow Articles by Malissen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magnan, A.
Right arrow Articles by Malissen, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2001/8/491/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 4, August 20, 2001 491-506


Original Article

T Cell Development and T Cell Responses in Mice with Mutations Affecting Tyrosines 292 or 315 of the Zap-70 Protein Tyrosine Kinase

Antoine Magnana, Vincenzo Di Bartolob, Anne-Marie Muraa, Claude Boyera, Mireille Richelmea, Yea-Lih Lina, Agnès Rourea, Anne Gilleta, Cécile Arrieumerlouc, Oreste Acutob, Bernard Malissena, and Marie Malissena

a Centre d'Immunologie de Marseille-Luminy, Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Univ.Med., Parc Scientifique de Luminy, 13288 Marseille Cedex 9, France
b Molecular Immunology Unit, Institut Pasteur, 75724 Paris Cedex 15, France
c Laboratoire d'Immuno-Pharmacologie, CNRS UPR 415, Institute Cochin de Génètique Moléculaire, 75014 Paris, France
Centre d'Immunologie de Marseille-Luminy Case 906, Parc Scientifique de Luminy, 13288 Marseille Cedex 9, France.33-491-2694-3033-491-2694-02

malissen{at}ciml.univ-mrs.fr

After stimulation of the T cell receptor (TCR), the tyrosine residues 292 and 315 in interdomain B of the protein tyrosine kinase ZAP-70 become phosphorylated and plausibly function as docking sites for Cbl and Vav1, respectively. The two latter proteins have been suggested to serve as substrates for ZAP-70 and to fine-tune its function. To address the role of these residues in T cell development and in the function of primary T cells, we have generated mice that express ZAP-70 molecules with Tyr to Phe substitution at position 292 (Y292F) or 315 (Y315F). When analyzed in a sensitized TCR transgenic background, the ZAP-70 Y315F mutation reduced the rate of positive selection and delayed the occurrence of negative selection. Furthermore, this mutation unexpectedly affected the constitutive levels of the CD3-{zeta} p21 phosphoisoform. Conversely, the ZAP-70 Y292F mutation upregulated proximal events in TCR signaling and allowed more T cells to produce interleukin 2 and interferon {gamma} in response to a given dose of antigen. The observation that ZAP-70 Y292F T cells have a slower rate of ligand-induced TCR downmodulation suggests that Y292 is likely involved in regulating the duration activated TCR reside at the cell surface. Furthermore, we showed that Y292 and Y315 are dispensable for the TCR-induced tyrosine phosphorylation of Cbl and Vav1, respectively. Therefore, other molecules present in the TCR signaling cassette act as additional adaptors for Cbl and Vav1. The present in vivo analyses extend previous data based on transformed T cell lines and suggest that residue Y292 plays a role in attenuation of TCR signaling, whereas residue Y315 enhances ZAP-70 function.

Key Words: gene knockin • T cell antigen receptor • Vav1 • Cbl • signal transduction


Abbreviations used in this paper: DN, double negative; DP, double positive; ES, embryonic stem; ITAM, immunoreceptor tyrosine-based activation motif; PLC, phospholipase C; PTK, protein tyrosine kinase; SH, src homology; SP, single positive.

© 2001 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS